Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors
Breast cancer is the most commonly diagnosed cancer among women, but despite survival rates improvement, it is still the second major cause of cancer related death. In postmenopausal women with estrogen receptor (ER) dependent breast cancer, hormone therapy is an option, either by direct inhibition...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Portuguesa de Reumatologia
2015-10-01
|
| Series: | Acta Reumatológica Portuguesa |
| Subjects: | |
| Online Access: | http://www.actareumatologica.com/files/article/1101_management_of_bone_loss_in_postmenopausal_breast_cancer_patients_treated_with_aromatase_inhibitors_file.pdf |